BioCardia, Inc. is a clinical stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. Its lead therapeutic candidate is the CardiAMP cell therapy system and its second therapeutic candidate is the CardiALLO cell therapy system. BioCardia is headquartered in San Carlos, California.
Quote | BioCardia Inc. (OTCMKTS:BCDA)
Last: | $ |
---|---|
Change Percent: | 3.10% |
Open: | $4.73 |
Close: | $4.66 |
High: | $4.73 |
Low: | $4.6348 |
Volume: | 2,064 |
Last Trade Date Time: | 02/12/2020 04:27:18 pm |
News | BioCardia Inc. (OTCMKTS:BCDA)
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Unites States Patent Office has granted Patent No: 12,036,371 ti...
MULHOUSE, France, and SUNNYVALE, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovasc...
Message Board Posts | BioCardia Inc. (OTCMKTS:BCDA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BCDA News Article - BioCardia Letter to Shareholders | whytestocks | investorshangout | 12/22/2022 4:15:44 PM |
whytestocks: $BCDA News Article - BioCardia Reports Third Quarter 2022 Business Highlights and Finan | whytestocks | investorshangout | 11/09/2022 9:15:53 PM |
whytestocks: $BCDA News Article - BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Tr | whytestocks | investorshangout | 10/03/2022 4:50:59 PM |
whytestocks: $BCDA News Article - BioCardia to Participate in Cantor Fitzgerald's Cell and Genetic M | whytestocks | investorshangout | 09/08/2022 5:30:48 PM |
whytestocks: $BCDA News Article - BioCardia Announces Positive DSMB Review and Recommendation to Con | whytestocks | investorshangout | 08/31/2022 2:20:49 PM |
News, Short Squeeze, Breakout and More Instantly...
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Unites States Patent Office has granted Patent No: 12,036,371 ti...
SUNNYVALE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the Unites States Patent Office has granted Patent No: ...